Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Buzz on the Bullboards: What’s Hot This Summer?


Stockhouse Editorial
0 Comments| July 6, 2018

{{labelSign}}  Favorites
{{errorMessage}}

Stockhouse investors know what has been the dominant theme for much of 2018: cannabis. However, we’re now well into summer – typically the doldrums for investor activity. Indeed, most small cap valuations have been retreating in recent weeks.

But not all investors are surrendering to summer vacations and backyard barbeques. For those investors who are still avidly plugged into markets – and their favorite stocks – where are the current hot-spots for such activity?

Cannabis does lead the way, with “the usual suspects” topping our cannabis leaderboard: Canopy Growth Corp (TSX: WEED, NYSE: CGC, Forum) and Aurora Cannabis Inc. (TSX: ACB, OTCQB: ACBFF, Forum). But while we were snoozing here at Stockhouse, a new entrant rose to the top last week – before slipping below 6th position this week: FSD Pharma Inc. (CSE: HUGE, OTCQB: FSDDF, Forum).

Click to enlarge

HUGE just acquired its CSE listing on May 29, 2018, but the Company is already making waves. Here’s an interesting note for investors. While Bullboard activity spiked for FSD Pharma last week, HUGE just announced a $55 million dollar dealthis week. Once again, there was significant “buzz” at Stockhouse in advance of major news.

While investor activity is generally lower across the board, there were/are still pockets of intense investor interest. One example is on our Metals & Mining leaderboard. It’s been a tough year (so far) for most mining companies, but one company that is riding a wave of interest right now is Lucara Diamond Corp (TSX: LUC, OTCQB: LUCRF, Forum).

Lucara has significant support at Stockhouse and has occasionally appeared among the mining leaders in the past. Suddenly, LUC has appeared in the Top-6 in consecutive weeks. Is some big diamond news on the way? The one-month chart shows the company trending higher recently.

BuzzJul6_Lucara.png

(click to enlarge)

On the Healthcare Bullboards, there is also a company attracting some sustained interest, outside of some of the perennial favorites here. ICO Therapeutics Inc. (TSX: V.ICO, OTCQB: ICOTF, Forum),has been in the #2 position among Healthcare leaders for two weeks in a row.

In this case, we have a company whose share price started making a move and then Bullboard interest jumped. As recently as June 20, 2018, ICO was trading at $0.06. On June 21st, the stock spiked to $0.20, before giving back a little ground more recently. This coincides with important news from the company on its new clinical trial.

BuzzJul6_ICO.png

(click to enlarge)

One long-time Stockhouse favorite that is generating significant interest on its Bullboard and delivering impressive recent gains for investors is industrials heavyweight, Bombardier Inc. (TSX: BBD.A, OTCQX: BDRBF, Forum). The company has recently announced several new deals as well as the successful conclusion of a new labour agreement.

The market has rewarded Bombardier with nearly a 50% gain over the past three months. That’s a very impressive performance for this Canadian large cap. The one-year performance for Bombardier is even stronger, more than doubling for BBD investors.

BuzzJul6_BBD.png

(click to enlarge)

It’s summer in Canada, the one time of the year where Canadians are prone to getting hot-under-the-collar. So many investors take a break from markets and a much greater interest in R&R. For those still actively trading, there are companies on the move (upward) that certainly bear watching. And there is no better place for small-cap investors to stay on top of markets than Stockhouse.

FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}